US2010298564A1PendingUtilityA1
Preparation of amorphous valganciclovir hydrochloride
Est. expiryMay 25, 2029(~2.8 yrs left)· nominal 20-yr term from priority
C07D 473/18
18
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application relates to processes for the preparation amorphous valganciclovir hydrochloride, comprising combining a solution of valganciclovir with an anti-solvent.
Claims
exact text as granted — not AI-modified1 . A process for preparing amorphous valganciclovir hydrochloride, comprising:
a) providing a solution of valganciclovir hydrochloride in a solvent; b) combining the solution of valganciclovir hydrochloride with an anti-solvent; and c) isolating a solid from the mixture of b).
2 . The process of claim 1 , further comprising washing the solid with an anti-solvent.
3 . The process of claim 1 , further comprising delumping or milling the solid.
4 . The process of claim 1 , further comprising drying the solid at temperatures less than about 120° C.
5 . The process of claim 1 , wherein a solvent comprises an alcohol, a glycol, N,N-dimethylformamide, dimethylsulfoxide, N,N-dimethylacetamide, water, or any mixtures thereof.
6 . The process of claim 1 , wherein a solvent comprises methanol.
7 . The process of claim 1 , wherein an anti-solvent comprises isopropyl alcohol, 1-propanol, 1-butanol, 2-ethoxymethanol, methyl acetate, ethyl acetate, isopropyl acetate, acetone, methyl ethyl ketone, diethyl ether, methyl t-butyl ether, tetrahydrofuran, toluene, acetonitrile, or any mixtures thereof.
8 . The process of claim 1 , wherein a solution of valganciclovir hydrochloride is combined with an anti-solvent at about −20° C. to about 50° C.
9 . The process of claim 1 , wherein combining comprises adding a solution of valganciclovir hydrochloride to an anti-solvent.
10 . The process of claim 1 , wherein times for combining a solution of valganciclovir hydrochloride with an anti-solvent range from about 10 minutes to about 90 minutes.
11 . The process of claim 2 , wherein a solid is washed with an anti-solvent comprising isopropyl alcohol, 1-propanol, 1-butanol, 2-ethoxymethanol, methyl acetate, ethyl acetate, isopropyl acetate, acetone, methyl ethyl ketone, diethyl ether, methyl t-butyl ether, tetrahydrofuran, toluene, acetonitrile, or any mixtures thereof.
12 . A process for preparing amorphous valganciclovir hydrochloride, comprising:
a) providing a solution of valganciclovir hydrochloride in a solvent comprising an alcohol; b) combining the solution of valganciclovir hydrochloride with an anti-solvent; and c) isolating a solid from the mixture of b).
13 . The process of claim 12 , wherein a solvent comprises methanol.
14 . The process of claim 12 , wherein an anti-solvent comprises isopropyl alcohol, 1-propanol, 1-butanol, 2-ethoxymethanol, methyl acetate, ethyl acetate, isopropyl acetate, acetone, methyl ethyl ketone, diethyl ether, methyl t-butyl ether, tetrahydrofuran, toluene, acetonitrile, or any mixtures thereof.
15 . The process of claim 12 , wherein an anti-solvent comprises methyl ethyl ketone or isopropyl alcohol.
16 . The process of claim 12 , wherein a solution of valganciclovir hydrochloride is combined with an anti-solvent at about −20° C. to about 50° C.
17 . The process of claim 12 , wherein combining comprises adding a solution of valganciclovir hydrochloride to an anti-solvent.
18 . The process of claim 12 , wherein times for combining a solution of valganciclovir hydrochloride with an anti-solvent range from about 10 minutes to about 90 minutes.
19 . A process for preparing amorphous valganciclovir hydrochloride, comprising:
a) providing a solution of valganciclovir hydrochloride in a solvent comprising methanol; b) combining the solution of valganciclovir hydrochloride with an anti-solvent comprising methyl ethyl ketone or isopropanol; and c) isolating a solid from the mixture of b).Join the waitlist — get patent alerts
Track US2010298564A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.